Literature DB >> 8618297

Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia.

K E el Din1, W F Koch, M J de Wildt, L A Kiemeney, F M Debruyne, J J de la Rosette.   

Abstract

PURPOSE: The reliability of the International Prostate Symptom Score (I-PSS) was tested in patients with lower urinary tract symptoms and/or benign prostatic hyperplasia.
MATERIALS AND METHODS: A total of 71 consecutive men with benign prostatic hyperplasia and/or lower urinary tract symptoms was asked to complete the I-PSS at baseline and 8 weeks later. At the second visit the physician also completed the I-PSS according to the complaints of the patient. Variability between both scores was evaluated by calculation of duplo errors and results were compared to the clinical data.
RESULTS: A considerable variability existed between the I-PSS results obtained at baseline and 8 weeks. The duplo error was 4.3. In a regression analysis of I-PSS, including all clinical parameters, only free flow had some predictive value for I-PSS outcomes.
CONCLUSIONS: It is important to consider the variability of the I-PSS score when making decisions concerning treatment.

Entities:  

Mesh:

Year:  1996        PMID: 8618297     DOI: 10.1097/00005392-199606000-00041

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  The International Prostate Symptom Score (IPSS) Is an Inadequate Tool to Screen for Urethral Stricture Recurrence After Anterior Urethroplasty.

Authors:  Christopher A Tam; Sean P Elliott; Bryan B Voelzke; Jeremy B Myers; Alex J Vanni; Benjamin N Breyer; Thomas G Smith; Christopher D McClung; Bradley A Erickson
Journal:  Urology       Date:  2016-04-21       Impact factor: 2.649

2.  Primary urethral reconstruction results in penile fracture.

Authors:  R Barros; Mis Silva; V Antonucci; L Schulze; L Koifman; L A Favorito
Journal:  Ann R Coll Surg Engl       Date:  2017-09-15       Impact factor: 1.891

3.  Long-Term Effects of a Randomised Controlled Trial Comparing High Protein or High Carbohydrate Weight Loss Diets on Testosterone, SHBG, Erectile and Urinary Function in Overweight and Obese Men.

Authors:  Lisa J Moran; Grant D Brinkworth; Sean Martin; Thomas P Wycherley; Bronwyn Stuckey; Janna Lutze; Peter M Clifton; Gary A Wittert; Manny Noakes
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

4.  PRISMA-combined α-blockers and antimuscarinics for ureteral stent-related symptoms: A meta-analysis.

Authors:  Yu-Ming Zhang; Pei Chu; Wen-Jin Wang
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

5.  Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy.

Authors:  Christopher H Chapman; Steve E Braunstein; Jean Pouliot; Susan M Noworolski; Vivian Weinberg; Adam Cunha; John Kurhanewicz; Alexander R Gottschalk; Mack Iii Roach; I-Chow Hsu
Journal:  J Contemp Brachytherapy       Date:  2018-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.